Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin 1.5% Ophthalmic Drop as Antibiotic Prophylaxis After LASIK or SMILE (CRVT Study)
KCT0011907Phase 4Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in corneal infection, sponsored by Santen Pharmaceutical. Started Dec 2024; status: completed.
02
Drugs
levofloxacin
03
Conditions
corneal infection
Beyond the preview
Go deeper on KCT0011907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011907.